Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 3
2009 2
2010 6
2011 3
2012 2
2013 3
2014 4
2015 6
2016 4
2017 4
2018 2
2019 4
2020 5
2021 8
2022 8
2023 8
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

65 results

Results by year

Filters applied: . Clear all
Page 1
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis.
Harrison SA, Bedossa P, Guy CD, Schattenberg JM, Loomba R, Taub R, Labriola D, Moussa SE, Neff GW, Rinella ME, Anstee QM, Abdelmalek MF, Younossi Z, Baum SJ, Francque S, Charlton MR, Newsome PN, Lanthier N, Schiefke I, Mangia A, Pericàs JM, Patil R, Sanyal AJ, Noureddin M, Bansal MB, Alkhouri N, Castera L, Rudraraju M, Ratziu V; MAESTRO-NASH Investigators. Harrison SA, et al. N Engl J Med. 2024 Feb 8;390(6):497-509. doi: 10.1056/NEJMoa2309000. N Engl J Med. 2024. PMID: 38324483 Clinical Trial.
Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study.
Qin S, Chan SL, Gu S, Bai Y, Ren Z, Lin X, Chen Z, Jia W, Jin Y, Guo Y, Hu X, Meng Z, Liang J, Cheng Y, Xiong J, Ren H, Yang F, Li W, Chen Y, Zeng Y, Sultanbaev A, Pazgan-Simon M, Pisetska M, Melisi D, Ponomarenko D, Osypchuk Y, Sinielnikov I, Yang TS, Liang X, Chen C, Wang L, Cheng AL, Kaseb A, Vogel A; CARES-310 Study Group. Qin S, et al. Lancet. 2023 Sep 30;402(10408):1133-1146. doi: 10.1016/S0140-6736(23)00961-3. Epub 2023 Jul 24. Lancet. 2023. PMID: 37499670 Clinical Trial.
The neurogliovascular unit in hepatic encephalopathy.
Claeys W, Van Hoecke L, Lefere S, Geerts A, Verhelst X, Van Vlierberghe H, Degroote H, Devisscher L, Vandenbroucke RE, Van Steenkiste C. Claeys W, et al. Among authors: van steenkiste c. JHEP Rep. 2021 Aug 11;3(5):100352. doi: 10.1016/j.jhepr.2021.100352. eCollection 2021 Oct. JHEP Rep. 2021. PMID: 34611619 Free PMC article. Review.
An unexpected liver lesion?
De Somer T, D'Hondt M, Carels K, Monsaert E, Bouderez V, Vanderstraeten E, Alaerts H, Van Steenkiste C. De Somer T, et al. Among authors: van steenkiste c. Acta Gastroenterol Belg. 2021 Apr-Jun;84(2):385-386. doi: 10.51821/84.2.385. Acta Gastroenterol Belg. 2021. PMID: 34217196 Free article. No abstract available.
Experimental hepatic encephalopathy causes early but sustained glial transcriptional changes.
Claeys W, Van Hoecke L, Lernout H, De Nolf C, Van Imschoot G, Van Wonterghem E, Verhaege D, Castelein J, Geerts A, Van Steenkiste C, Vandenbroucke RE. Claeys W, et al. Among authors: van steenkiste c. J Neuroinflammation. 2023 May 29;20(1):130. doi: 10.1186/s12974-023-02814-w. J Neuroinflammation. 2023. PMID: 37248507 Free PMC article.
Clinical significance and impact of gastric non-Helicobacter pylori Helicobacter species in gastric disease.
Taillieu E, De Witte C, De Schepper H, Van Moerkercke W, Rutten S, Michiels S, Arnst Y, De Bruyckere S, Francque S, van Aert F, George C, Callewaert E, Callewaert T, Vanneste G, Vanderstraeten E, Van Heddegem N, Vansteelant M, Chiers K, Haesebrouck F, Van Steenkiste C. Taillieu E, et al. Among authors: van steenkiste c. Aliment Pharmacol Ther. 2023 Jun;57(12):1432-1444. doi: 10.1111/apt.17488. Epub 2023 Mar 28. Aliment Pharmacol Ther. 2023. PMID: 36975151
Alteration of protein glycosylation in liver diseases.
Blomme B, Van Steenkiste C, Callewaert N, Van Vlierberghe H. Blomme B, et al. Among authors: van steenkiste c. J Hepatol. 2009 Mar;50(3):592-603. doi: 10.1016/j.jhep.2008.12.010. Epub 2008 Dec 27. J Hepatol. 2009. PMID: 19157620 Review.
Angiogenesis in chronic liver disease and its complications.
Coulon S, Heindryckx F, Geerts A, Van Steenkiste C, Colle I, Van Vlierberghe H. Coulon S, et al. Among authors: van steenkiste c. Liver Int. 2011 Feb;31(2):146-62. doi: 10.1111/j.1478-3231.2010.02369.x. Epub 2010 Nov 15. Liver Int. 2011. PMID: 21073649 Review.
65 results